Original language | English (US) |
---|---|
Pages (from-to) | 1110 |
Number of pages | 1 |
Journal | The Lancet Infectious Diseases |
Volume | 16 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2016 |
ASJC Scopus subject areas
- Infectious Diseases
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Overlooking the importance of immunoassays – Authors' reply. / Cnops, Lieselotte; van Griensven, Johan; Honko, Anna N. et al.
In: The Lancet Infectious Diseases, Vol. 16, No. 10, 01.10.2016, p. 1110.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Overlooking the importance of immunoassays – Authors' reply
AU - Cnops, Lieselotte
AU - van Griensven, Johan
AU - Honko, Anna N.
AU - Bausch, Daniel G.
AU - Sprecher, Armand
AU - Hill, Charles E.
AU - Colebunders, Robert
AU - Johnson, Joshua C.
AU - Griffiths, Anthony
AU - Palacios, Gustavo F.
AU - Kraft, Colleen S.
AU - Kobinger, Gary
AU - Hewlett, Angela
AU - Norwood, David A.
AU - Sabeti, Pardis
AU - Jahrling, Peter B.
AU - Formenty, Pierre
AU - Kuhn, Jens H.
AU - Ariën, Kevin K.
N1 - Funding Information: The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, the US Department of Defense, the US Department of the Army, WHO, or the institutions and companies affiliated with the authors. This work was funded in part through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under contract number HHSN272200700016I. JCJ is an employee of Battelle Memorial Institute. JHK is a subcontractor to Battelle Memorial Institute, and an employee of Tunnell Government Services, Inc. LC holds an innovation mandate from the Agency for Innovation by Science and Technology (IWT) from the Flemish Government. JvG is supported by the European Union's Horizon 2020 research and innovation programme under grant agreement number 666094. KKA has received a speaker fee from Biocartis. All other authors declare no competing interests.
PY - 2016/10/1
Y1 - 2016/10/1
UR - http://www.scopus.com/inward/record.url?scp=84990030037&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84990030037&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(16)30339-5
DO - 10.1016/S1473-3099(16)30339-5
M3 - Letter
C2 - 27676345
AN - SCOPUS:84990030037
SN - 1473-3099
VL - 16
SP - 1110
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 10
ER -